Inhibition of Neovascularization to Simultaneously Ameliorate Graft-vs-Host Disease and Decrease Tumor Growth
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of Neovascularization to Simultaneously Ameliorate Graft-vs-Host Disease and Decrease Tumor Growth
Authors
Keywords
-
Journal
JNCI-Journal of the National Cancer Institute
Volume 102, Issue 12, Pages 894-908
Publisher
Oxford University Press (OUP)
Online
2010-05-13
DOI
10.1093/jnci/djq172
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Enzastaurin, an inhibitor of PKCβ, Enhances Antiangiogenic Effects and Cytotoxicity of Radiation against Endothelial Cells
- (2014) Aaron C. Spalding et al. Translational Oncology
- Modulation of the "blood-tumor" barrier improves immunotherapy
- (2010) Mitali Manzur et al. CELL CYCLE
- NOD2 regulates hematopoietic cell function during graft-versus-host disease
- (2009) Olaf Penack et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Inhibition of Chronic and Acute Skin Inflammation by Treatment with a Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor
- (2008) Cornelia Halin et al. AMERICAN JOURNAL OF PATHOLOGY
- Vascular Endothelial Growth Factor Gene Polymorphisms May Predict the Risk of Acute Graft-versus-Host Disease following Allogeneic Transplantation: Preventive Effect of Vascular Endothelial Growth Factor Gene on Acute Graft-versus-Host Disease
- (2008) Dong Hwan Kim et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Angiopoietin-2 predicts disease-free survival after allogeneic stem cell transplantation in patients with high-risk myeloid malignancies
- (2008) P. Kumpers et al. BLOOD
- Matrix Metalloproteinase-9 Is Required for Tumor Vasculogenesis but Not for Angiogenesis: Role of Bone Marrow-Derived Myelomonocytic Cells
- (2008) G-One Ahn et al. CANCER CELL
- Antiangiogenic Therapy with Mammalian Target of Rapamycin Inhibitor RAD001 (Everolimus) Increases Radiosensitivity in Solid Cancer
- (2008) P. C. Manegold et al. CLINICAL CANCER RESEARCH
- Curcumin Sensitizes Human Colorectal Cancer Xenografts in Nude Mice to -Radiation by Targeting Nuclear Factor- B-Regulated Gene Products
- (2008) A. B. Kunnumakkara et al. CLINICAL CANCER RESEARCH
- Combination of Vascular Endothelial Growth Factor Receptor/Platelet-Derived Growth Factor Receptor Inhibition Markedly Improves Radiation Tumor Therapy
- (2008) C. Timke et al. CLINICAL CANCER RESEARCH
- Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors
- (2008) Johannes L Zakrzewski et al. NATURE BIOTECHNOLOGY
- Tumor Angiogenesis
- (2008) Robert S. Kerbel NEW ENGLAND JOURNAL OF MEDICINE
- M867, a Novel Selective Inhibitor of Caspase-3 Enhances Cell Death and Extends Tumor Growth Delay in Irradiated Lung Cancer Models
- (2008) Kwang Woon Kim et al. PLoS One
- Endothelial Progenitor Cells Control the Angiogenic Switch in Mouse Lung Metastasis
- (2008) D. Gao et al. SCIENCE
- Recombinant Human Erythropoietin alpha Improves the Efficacy of Radiotherapy of a Human Tumor Xenograft, Affecting Tumor Cells and Microvessels
- (2008) József Lövey et al. STRAHLENTHERAPIE UND ONKOLOGIE
- VE-Cadherin
- (2007) Dietmar Vestweber ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started